Pfizer (PFE) Dividends payables (2009 - 2025)

Pfizer (PFE) has 17 years of Dividends payables data on file, last reported at $2.4 billion in Q4 2025.

• Quarterly Dividends payables changed 0.33% year-over-year to $2.4 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 billion (changed 0.33% YoY) and the FY2025 annual result came in at $2.4 billion, changed 0.33% from the prior year.
• Dividends payables held at $2.4 billion in Q4 2025 per PFE's latest filing, from $2.4 billion in the prior quarter.
• Across five years, Dividends payables topped out at $2.4 billion in Q2 2025 and bottomed at $2.2 billion in Q3 2021.
• The 5-year median for Dividends payables is $2.3 billion (2022), against an average of $2.3 billion.
• The widest annual swing landed in 2021, when Dividends payables rose 4.02%; it then climbed 0.33% in 2025.
• Tracing PFE's Dividends payables over 5 years: stood at $2.2 billion in 2021, then gained by 2.4% to $2.3 billion in 2022, then climbed by 3.0% to $2.4 billion in 2023, then rose by 2.74% to $2.4 billion in 2024, then grew by 0.33% to $2.4 billion in 2025.
• Per Business Quant, the three latest PFE Dividends payables figures stand at $2.4 billion (Q4 2025), $2.4 billion (Q2 2025), and $2.4 billion (Q4 2024).

Peer Comparison